With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market.
Related Posts
Supreme Court Imperils an Array of Federal Rules
The Supreme Court’s decision on Friday to limit the broad regulatory authority of federal agencies could lead to the elimination…
The State That Chose to Cover Obesity Drugs for Its Poor, but Not Its Own Employees
The widespread use and enormous expense of blockbuster drugs like Wegovy are forcing state governments to make painful choices.
Caroline Kennedy Calls RFK Jr. a ‘Predator’ in Letter to Senators
In a harsh letter to lawmakers considering Robert F. Kennedy Jr.’s nomination for health secretary, Ms. Kennedy called her cousin…
